Abstract:Park et al1Park S.W. Lee K.J. Chung M.J. et al.Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial.Gastrointest Endosc. 2023; 97: 132-142.e2Abstract Full Text Full Text PDF Scopus (2) Google Scholar reported no significant differences in the 6-month stent patency rates and mortality between partially covered and uncovered double bare self-expandable metal stents (PCDBSs vs UCDBSs) for unresectable distal malignant biliary obstruction. This randomized controlled multicenter trial is of great significance for clinical practice, yet we would like to share our reservations for further research. First, as shown in the baseline characteristics section, the length of the stricture was longer in PCDBSs than in UCDBSs (2.8 ± 1.3 vs 2.4 ± 1.2, P = .010). The length or the degree of stricture might be correlated with disease severity and stent patency,2Kim H.S. Lee D.K. Kim H.G. et al.Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study.Gastrointest Endosc. 2002; 55: 359-365Abstract Full Text Full Text PDF PubMed Scopus (92) Google Scholar and longer biliary stricture was an independent risk factor for worse survival after metal stent insertion,3Zu Q.Q. Zhang J.X. Wang B. et al.Percutaneous transpapillary biliary stent placement for distal malignant biliary obstruction: outcomes and survival analysis.Turk J Gastroenterol. 2019; 30: 714-721Crossref Scopus (5) Google Scholar which is also in accord with the fact that the rate of tumor overgrowth was higher in the PCDBS group than in the UCDBS group (5.5% vs 0.8%). Therefore, we hypothesize that the PCDBS group had selection bias, which would weaken the effect of PCDBSs on stent patency and overall survival, and a propensity-matching analysis may be required. Second, we would like to know whether there was a significant difference in the total incidence of single adverse events between the 2 groups, regardless of the 2-week time limit, so as to better verify the overall impact of whether or not the novel metal stent is covered on the risk of adverse events.4Dumonceau J.M. Kapral C. Aabakken L. et al.ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline.Endoscopy. 2020; 52: 127-149Crossref PubMed Scopus (331) Google Scholar Third, the authors did not disclose the details of revision for stent dysfunction, which might have had some influence on stent patency and overall survival. For example, radiofrequency ablation can be performed by both endoscopic and percutaneous routes. As a novel adjunctive procedure and a promising therapeutic option in patients with malignant biliary obstruction, radiofrequency ablation can achieve local tumor control, resulting in improved biliary stent patency and a potential survival benefit.5Inoue T. Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction.Dig Endosc. 2022; 34: 345-358Crossref PubMed Scopus (22) Google Scholar Both authors disclosed no financial relationships.

Current status of covered self-expandable biliary metallic stent

Biliary stents for active materials and surface modification: Recent advances and future perspectives

Clinical Application of Endoscopic Metal Biliary Endoprosthesis for Treatment of Malignant Biliary Obstruction

Advances in functional coatings on biliary stents

Progress in the application study of biliary endoprosthesis

The Progress of Biodegradable Biliary Stents

Double Bare Self-Expandable Metal Stent for Distal Malignant Biliary Obstruction.

A review on biodegradable biliary stents: materials and future trends

A novel biliary stent coated with silver nanoparticles prolongs the unobstructed period and survival via anti-bacterial activity

A Retrospective Study of 512 Malignant Esophageal Strictures Treated with Covered Self-Expanding Metal Stent

Implantation of Covered Self-expandable Metal Stent in the Common Bile Duct for the Treatment of Choledochoduodenal Fistula

Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years

Recent research progresses of bioengineered biliary stents

Membrane-covered Self-Expanding Stents in the Treatment of High-Positioned Esophageal Stenosis or Fistula

Study of Biodegradable and Self-Expandable PLLA Helical Biliary Stent in Vivo and in Vitro

Clinical application and value of digestive tract stents

Efficacy and safety of a novel polytetrafluoroethylene-coated self-expandable metal stent for distal malignant biliary obstruction

Treatment of Advanced Esophageal Carcinoma with Membrane-covered Metallic Stent

[Long-term retrospective analysis of metallic stents in malignant biliary obstruction]

A novel fully covered self-expandable segmental metallic stents for the treatment of refractory esophageal stenosis

Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: a multicentre trial.